Picture of Apontis Pharma AG logo

APPH — Apontis Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Apontis Pharma Withdraws Forecast For Fiscal Year 2023 And Medium-Term Planning For 2026

July 27 (Reuters) - Apontis Pharma Ag  APPHG.DE :
    * EQS-ADHOC: APONTIS PHARMA AG WITHDRAWS FORECAST FOR FISCAL
YEAR
2023 AND MEDIUM-TERM PLANNING FOR 2026
    * Apontis Pharma Ag  APPHG.DE  - REASON FOR THIS IS A SLOWER
GROWTH OF SINGLE PILL BUSINESS THAN INITIALLY EXPECTED
    * Apontis Pharma Ag  APPHG.DE  - A FORECAST FOR FISCAL YEAR
2023
CANNOT YET BE ISSUED AT PRESENT TIME
    * Apontis Pharma Ag  APPHG.DE  - EXPENSES RELATED TO
RESIGNATION
OF FORMER CEO KARLHEINZ GAST WILL LEAD TO AN ADDITIONAL COST
BURDEN
    * Apontis Pharma Ag  APPHG.DE  - COMPANY HAS BEGUN PREPARING
A
PROGRAM TO INCREASE OPERATIONAL PERFORMANCE AND EFFICIENCY
    * Apontis Pharma Ag  APPHG.DE  - EVALUATING STRATEGIC
OPTIONS FOR
SALES AND MARKETING ACTIVITIES TO INCREASE SALES

Source text for Eikon:  ID:nEQ7tKQ9xa 
Further company coverage:  APPHG.DE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Apontis Pharma AG

See all news